Radiopharmaceuticals: hot or not?

The radiopharmaceuticals sector is attracting interest from private equity and corporates alike, but what does it take to succeed in a sector where barriers to entry remain high? asks Florence Wang, senior analyst at Mansfield Advisors LLP Despite a market size of US$5.2bn in 2018, radiopharmaceuticals represent less than 1% of the global pharmaceutical industry…

You must be a HM Subscriber to view this content. Please log in or subscribe below.

Subscribe Now »